NCT05746455Completed
Motivation Skills Training for Schizophrenia
Motivation Skills Training to Enhance Functional Outcomes for People With Schizophrenia (Open Trial)
Source: ClinicalTrials.gov · Last updated 18 Dec 2024
Brief summary (registry, in English)
This study will take place at one outpatient clinic serving adults with serious mental illness and will recruit ten individuals (N=10) with a DSM-5 diagnosis of schizophrenia or schizoaffective disorder to participate in an Open Trial of Motivation Skills Training (MST). MST is a weekly group-based skills training intervention that aims to improve knowledge about one's level and sources of motivation, the ability to monitor and regulate (understand and manage) motivation, so that one can better initiate and sustain goal-directed behavior. Participants who consent for research will complete assessments of motivation, goal attainment, quality of life, executive functioning, community functioning, and psychiatric symptoms severity. The intervention phase will be approximately 12 weeks in duration and will entail weekly MST group sessions. At treatment endpoint, participants will be asked to repeat the assessment battery from baseline as well as a satisfaction survey. Change in motivation, goal attainment and quality of life will indicate whether MST is engaging the hypothesized target (motivation) and whether there is impact on functioning.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 8 (actual)
- First submitted
- 17 Feb 2023
- Start date
- 30 May 2023
- Primary completion date
- 31 Oct 2023
- Lead sponsor
- Columbia University
- Diseases
- Schizophrenia
- NCT number
- NCT05746455
What you commit to
- Study type: Interventional
- Participants enrolled: 8
- From 30 May 2023 to the primary completion date, 31 Oct 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Neurologic condition causing brain disease
- Mild to severe cognitive impairment associated with possible dementia
Other
- Indications of Intellectual Disability as documented in medical history or measured by \< 70 premorbid full scale Intelligence Quotient (IQ) estimate
- Severe substance use within the past 3 months determined by DSM-5 criteria
Who the study is looking for
- Age 18-65
- A primary Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 diagnosis of schizophrenia or schizoaffective disorder
- Medically and psychiatrically stable outpatient status
- English Fluency
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Bridge, Inc. Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.